LEADER 03076nam 2200961z- 450 001 9910595074003321 005 20231214133358.0 035 $a(CKB)5680000000080786 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92097 035 $a(EXLCZ)995680000000080786 100 $a20202209d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTreatments for Squamous Cell Cancer 210 $aBasel$cMDPI Books$d2022 215 $a1 electronic resource (168 p.) 311 $a3-0365-4757-6 311 $a3-0365-4758-4 330 $aSquamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes. 606 $aMedicine$2bicssc 606 $aOncology$2bicssc 610 $aoral cancer 610 $atobacco 610 $aalcohol 610 $ahuman papilloma virus 610 $atargeted sequencing 610 $aDNA copy number 610 $aTP53 610 $aCDKN2A 610 $aEGFR 610 $aPIK3CA 610 $aanal cancer 610 $aradiation therapy 610 $achemoradiation 610 $ade-escalation of therapy 610 $apain 610 $acathepsin S 610 $aprotease-activated receptor-2 610 $aPAR2 610 $acancer pain 610 $aoral squamous cell carcinoma 610 $adifferentiation 610 $aterminal differentiation 610 $aoral epithelium 610 $aepithelial integrity 610 $aepithelial transformation 610 $agenetic alterations 610 $atherapy response biomarkers 610 $acutaneous squamous cell carcinoma 610 $aimmunotherapy 610 $aanti-PD1 610 $abiomarkers 610 $apredictive medicine 610 $apersonalized medicine 610 $acancer 610 $aimmune system 610 $aHNSCC 610 $afarnesyl transferase 610 $atipifarnib 610 $acombination regimen 610 $aoropharynx 610 $aneoplasm 610 $asquamous cell carcinoma 610 $ahuman papillomavirus 610 $atherapeutic management 610 $atreatment selection 610 $aCSCC 610 $atreatment 610 $aadvances 610 $abiology 610 $aimmunocompromised 610 $aimmune checkpoint inhibition 615 7$aMedicine 615 7$aOncology 700 $aDarido$b Charbel$4edt$01332977 702 $aDarido$b Charbel$4oth 906 $aBOOK 912 $a9910595074003321 996 $aTreatments for Squamous Cell Cancer$93041180 997 $aUNINA